IndraLab

Statements


| 5 9

eidos
"Mebendazole downregulated USP5 expression and disrupted the interaction between USP5 and c-Maf , thus leading to increased levels of c-Maf ubiquitination and subsequent c-Maf degradation ."

reach
"Mebendazole inhibits the USP5 and c-Maf axis and induces c-Maf degradation via the ubiquitin-proteasome pathway."

eidos
"In the above studies , mebendazole was demonstrated to downregulate USP5 expression and disrupt the interaction between USP5 and c-Maf ."

reach
"The above studies provided strong evidence that mebendazole inhibits the USP5 and c-Maf axis and induces MM cell apoptosis."

reach
"The above results demonstrated that mebendazole suppressed the USP5 and c-Maf axis and promoted c-Maf degradation; therefore, mebendazole might downregulate the transcriptional activity of c-Maf."

reach
"The results showed that mebendazole decreased the USP5 content in the c-Maf immunoprecipitates in both exogenous and endogenous contexts, as shown in HEK293T and MM cells, respectively, suggesting that the interaction between USP5 and c-Maf was disrupted by mebendazole."

reach
"Collectively, these results thus showed marked synergy between mebendazole and USP5 inhibitors or anti-MM drugs such as daunorubicin.Mebendazole delays the growth of human multiple myeloma xenografts in a nude mouse model The above studies provided strong evidence that mebendazole inhibits the USP5 and c-Maf axis and induces MM cell apoptosis."

reach
"From this screen, we identified mebendazole, an agent widely used for the treatment of human gastrointestinal parasitic infections [XREF_BIBR], selectively induces MM cell apoptosis by targeting USP5 and c-Maf signaling."

eidos
"Mebendazole synergizes with WP1130 , an inhibitor of USP5 , because mebendazole downregulates USP5 expression and WP1130 inhibits USP5 deubiquitinase activity ."

reach
"From this screen, we identified mebendazole, an agent widely used for the treatment of human gastrointestinal parasitic infections [9], selectively induces MM cell apoptosis by targeting USP5 and c-Maf signaling.Cell culture Human embryonic kidney cells (HEK293T) were maintained in Dulbecco 's modified Eagle 's medium."

reach
"Mebendazole elicits potent antimyeloma activity by inhibiting the USP5 and c-Maf axis."

reach
"Mebendazole elicits potent antimyeloma activity by inhibiting the USP5 and c-Maf axis."

eidos
"Mebendazole inhibits USP5 expression and induces c-Maf degradation via the ubiquitin-proteasome pathway ."

eidos
"The above results showed that mebendazole downregulated c-Maf protein expression but had no effect on its mRNA expression ( Fig. 1 ) ; thus , we sought to determine whether mebendazole could suppress USP5 activity via c-Maf ubiquitination ."